Clinical Trial Update: Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life Conditions

View source ↗

Summary

A real-world study evaluating patient-reported outcomes in severe eosinophilic asthma patients treated with benralizumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED